{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T22:49:55Z","timestamp":1726181395899},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Advances in the management of human immunodeficiency virus infection during pregnancy have led to improved maternal health and significant declines in rates of mother-to-child transmission of human immunodeficiency virus. A critical contributor to this success has been the development of better tolerated, safer, and more convenient antiretroviral medication regimens. Today, 12 fixed-dose, single-tablet combination antiretroviral regimens are available in the United States. These regimens are commonly used in nonpregnant individuals. However, because of altered pharmacokinetics of many drugs during pregnancy and concerns regarding short- and long-term fetal safety, few of these regimens are appropriate for routine use in pregnancy.<\/jats:p>","DOI":"10.1097\/grf.0000000000000476","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T13:37:01Z","timestamp":1562938621000},"page":"804-815","source":"Crossref","is-referenced-by-count":2,"title":["Single-Tablet Combination Therapy for HIV Infection in Pregnancy"],"prefix":"10.1097","volume":"62","author":[{"given":"JENNIFER W.","family":"JANELLE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VIDHU","family":"KARIYAWASAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0033354918800466","article-title":"Reconsidering the number of women with HIV infection who give birth annually in the United States","volume":"133","author":"Nesheim","year":"2018","journal-title":"Public Health Rep"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/QAI.0000000000001552","article-title":"Brief Report: estimated incidence of perinatally acquired HIV infection in the United States, 1978\u20132013","volume":"76","author":"Nesheim","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-20230911","first-page":"1715","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N Engl J Med"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"e1001217","DOI":"10.1371\/journal.pmed.1001217","article-title":"Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial","volume":"9","author":"Gibb","year":"2012","journal-title":"PLoS Med"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/jix542","article-title":"Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study","volume":"216","author":"Pintye","year":"2017","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"R11-20230911","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000000231","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis","volume":"28","author":"Ford","year":"2014","journal-title":"AIDS"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e32834cdb71","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis","volume":"25","author":"Ford","year":"2011","journal-title":"AIDS"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e32833a2a14","article-title":"Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0000000000000968","article-title":"Pharmacokinetics of rilpivirine in HIV-infected pregnant women","volume":"72","author":"Tran","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/QAD.0000000000001992","article-title":"Elvitegravir\/cobicistat pharmacokinetics in pregnant and postpartum women with HIV","volume":"32","author":"Momper","year":"2018","journal-title":"AIDS"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:17:15Z","timestamp":1694420235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000476","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}